AZURRX BIOPHARMA INC's ticker is AZRX and the CUSIP is 05502L105. A total of 20 filers reported holding AZURRX BIOPHARMA INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $27,000 | – | 20,000 | +4101.7% | 0.00% | – |
| Q3 2020 | $0 | – | 476 | +68.8% | 0.00% | – |
| Q2 2020 | $0 | – | 282 | +30.6% | 0.00% | – |
| Q1 2020 | $0 | -100.0% | 216 | -99.2% | 0.00% | – |
| Q3 2019 | $17,000 | -64.6% | 28,612 | +1.7% | 0.00% | – |
| Q2 2019 | $48,000 | – | 28,129 | +117104.2% | 0.00% | – |
| Q3 2018 | $0 | – | 24 | +2300.0% | 0.00% | – |
| Q4 2017 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q3 2017 | $0 | – | 1 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PARSONS CAPITAL MANAGEMENT INC/RI | 434,783 | $1,117,000 | 0.12% |
| J. Goldman & Co LP | 425,358 | $1,093,000 | 0.08% |
| 683 Capital Management, LLC | 400,000 | $1,028,000 | 0.07% |
| ARDSLEY ADVISORY PARTNERS LP | 150,000 | $386,000 | 0.05% |
| GILDER GAGNON HOWE & CO LLC | 556,537 | $1,430,000 | 0.02% |
| TIEDEMANN ADVISORS, LLC | 60,000 | $154,000 | 0.01% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 131,456 | $338,000 | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 22,780 | $59,000 | 0.01% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 500,000 | $1,285,000 | 0.00% |
| Rockefeller Capital Management L.P. | 16,971 | $44,000 | 0.00% |